HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Amer Beitinjaneh Selected Research
Amer Beitinjaneh Research Topics
Disease
11
Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022 - 02/2016
9
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 01/2016
8
Neoplasms (Cancer)
01/2022 - 09/2013
7
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
03/2022 - 06/2017
5
Hematologic Neoplasms (Hematological Malignancy)
01/2019 - 01/2017
3
Leukemia
01/2022 - 01/2018
3
Bronchiolitis Obliterans Syndrome
01/2022 - 01/2019
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 01/2018
3
Infections
01/2022 - 01/2019
2
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
06/2022 - 01/2020
2
Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
04/2022 - 05/2017
2
Viremia
01/2022 - 01/2018
2
Cytokine Release Syndrome
01/2022 - 01/2020
2
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 01/2018
2
Lymphoma (Lymphomas)
07/2021 - 02/2016
2
Hodgkin Disease (Hodgkin's Disease)
01/2021 - 01/2018
2
Cytopenia
01/2020 - 01/2018
2
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2019 - 01/2018
1
Residual Neoplasm
06/2022
1
cell-associated neurotoxicity
01/2022
1
Pneumonia (Pneumonitis)
01/2022
1
Hemorrhage
01/2022
1
Herpesviridae Infections (Herpesvirus Infection)
01/2022
1
Cryptogenic Organizing Pneumonia
01/2022
1
Critical Illness (Critically Ill)
01/2022
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2022
1
Multiple Myeloma
01/2022
1
Cytomegalovirus Infections (Inclusion Disease)
10/2021
1
COVID-19
08/2021
1
Febrile Neutropenia
01/2021
1
Dysbiosis
01/2021
1
Blast Crisis (Blast Phase)
10/2020
1
Bone Marrow Failure Disorders
01/2020
1
Body Weight (Weight, Body)
01/2020
1
Brain Edema (Cerebral Edema)
01/2020
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2020
1
B-Cell Lymphoma (Lymphoma, B Cell)
01/2020
1
Disease Progression
01/2020
1
Aplastic Anemia (Anemia, Hypoplastic)
10/2019
1
Seizures (Absence Seizure)
01/2019
1
Infertility (Sterility)
08/2017
1
Hypothyroidism
08/2017
1
Cataract (Cataracts)
08/2017
1
Stroke (Strokes)
08/2017
1
T-Cell Lymphoma (Lymphoma, T Cell)
05/2015
Drug/Important Bio-Agent (IBA)
7
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2022 - 02/2016
6
Chimeric Antigen Receptors
IBA
06/2022 - 01/2020
4
Antilymphocyte Serum (Anti-Thymocyte Globulin)
IBA
01/2022 - 02/2016
2
brexucabtagene autoleucel
IBA
06/2022 - 01/2020
2
Calcineurin Inhibitors
IBA
01/2022 - 02/2016
2
axicabtagene ciloleucel
IBA
01/2022 - 01/2020
2
Busulfan (Busulfex)
FDA Link
11/2021 - 01/2019
2
fludarabine
IBA
11/2021 - 03/2011
2
fms-Like Tyrosine Kinase 3
IBA
01/2016 - 07/2010
1
Methotrexate (Mexate)
FDA Link
Generic
01/2022
1
Mycophenolic Acid (Cellcept)
FDA Link
Generic
01/2022
1
Bortezomib (Velcade)
FDA Link
01/2022
1
Sirolimus (Rapamycin)
FDA Link
01/2022
1
Platinum
IBA
01/2022
1
Lenalidomide (CC 5013)
FDA Link
01/2022
1
Dexamethasone (Maxidex)
FDA Link
Generic
01/2022
1
Tacrolimus (Prograf)
FDA Link
Generic
01/2022
1
Melphalan (Alkeran)
FDA Link
Generic
11/2021
1
Immunosuppressive Agents (Immunosuppressants)
IBA
08/2021
1
Thiotepa (Triethylenethiophosphoramide)
FDA Link
Generic
07/2021
1
Penicillins (Penicillin)
FDA Link
01/2021
1
Cephalosporins (Cephalosporin Antibiotics)
IBA
01/2021
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2021
1
Carbapenems (Carbapenem Antibiotics)
IBA
01/2021
1
Monoclonal Antibodies
IBA
01/2021
1
Immune Checkpoint Inhibitors
IBA
01/2021
1
tisagenlecleucel
IBA
01/2020
1
Filgrastim (Neupogen)
FDA Link
01/2020
1
Agammaglobulinaemia Tyrosine Kinase
IBA
01/2020
1
Tyrosine Kinase Inhibitors
IBA
01/2020
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2020
1
Cytokines
IBA
01/2020
1
Phenytoin (Dilantin)
FDA Link
Generic
01/2019
1
Anticonvulsants (Antiepileptic Drugs)
IBA
01/2019
1
2-aminoethylmethyl sulfone
IBA
01/2019
1
DNA (Deoxyribonucleic Acid)
IBA
11/2018
1
Antiviral Agents (Antivirals)
IBA
01/2018
1
Antigens
IBA
01/2018
1
Alemtuzumab (Campath)
FDA Link
11/2017
1
Hormones (Hormone)
IBA
08/2017
1
Growth Hormone (Somatotropin)
IBA
08/2017
1
Bevacizumab (Avastin)
FDA Link
09/2013
1
Topotecan (Hycamtin)
FDA Link
Generic
09/2013
Therapy/Procedure
26
Cell Transplantation
04/2022 - 03/2011
15
Transplantation
04/2022 - 02/2016
13
Therapeutics
01/2022 - 01/2018
4
Drug Therapy (Chemotherapy)
01/2022 - 01/2020
4
Homologous Transplantation
11/2021 - 01/2016
3
Hematopoietic Stem Cell Transplantation
01/2022 - 01/2018
2
Stem Cell Transplantation
01/2022 - 05/2015
2
Haploidentical Transplantation
01/2022 - 01/2020
2
Activities of Daily Living (ADL)
01/2019 - 01/2019
1
Donor Selection
03/2022
1
Resuscitation
01/2020
1
Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2019